Lorazepam Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lorazepam Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Sep 5, 2018. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0641-6001-25
- Dosage Form
- Injection
- Presentation
- Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)
- Initial Posting
- Sep 5, 2018
Reason
Demand increase for the drug